Synthego raises funds from big names | Chemical & Engineering News
Volume 95 Issue 2 | p. 12 | Concentrates
Issue Date: January 9, 2017

Synthego raises funds from big names

Department: Business
Keywords: start-ups, venture investing, financing, CRISPR

Synthego, a four-year-old genome engineering tools firm, has raised $41 million in a Series B funding round. Investors include the technology venture firms 8VC and AME Cloud Ventures, backed by Yahoo founder Jerry Yang. Jennifer Doudna, a UC Berkeley professor and CRISPR/Cas9 pioneer, also invested. Synthego provides synthetic RNA sequences critical for employing CRISPR technology. The company was founded by former SpaceX engineers Paul and Michael Dabrowski.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment